Cannabinoids for the Control of multiple Sclerosis

摘要: In response to patient perceptions that cannabis can control some of the symptoms multiple sclerosis (MS), scientific studies in experimental models and clinical trials MS have been undertaken. These recent understanding biology cannabinoid system provided a rationale objective evidence support these perceptions. Indeed, first cannabis-based medicine for treatment signs has recently licensed use MS. Although most focused on symptom control, also indicates potential action cannabinoids autoim- mune neurodegenerative processes. drive underlying disease pathol- ogy cause varied symptomatology, which medicines may currently be used. future it possible harness medical benefits offer MS, whilst limiting adverse effects, both physical psycho-social, associated with smoking cannabis.